Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. administers about 385.6 mln doses of COVID-19 vaccines -CDC

09/19/2021 | 02:29pm EDT

Sept 19 (Reuters) - The United States has administered 385,586,012 doses of COVID-19 vaccines as of Sunday morning and distributed 466,561,785 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from 384,911,290 vaccine doses the CDC said had gone into arms by Sept. 18 out of 466,569,635 doses delivered.

The agency said 211,776,515 people had received at least one dose, while 181,382,976 people were fully vaccinated https://tmsnrt.rs/3tUM8ta as of 6 a.m. ET (1000 GMT) Sunday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech , as well as Johnson & Johnson's one-shot vaccine.

Over 2.16 million people have received an additional dose of either Pfizer or Moderna's vaccine since Aug. 13, when the U.S. authorized a third dose for those with compromised immune systems who are likely to have weaker protection from the two-dose regimens.

(Reporting by Vishal Vivek in Bengaluru; Editing by Lisa Shumaker)


ę Reuters 2021
All news about MODERNA, INC.
05:20pU.S. administers over 415 mln doses of COVID-19 vaccines - CDC
RE
04:23pFDA advisers back Pfizer's COVID-19 vaccine for young kids
AQ
02:39pModerna Announces First Participant Dosed in Phase 3 Pivotal Registration Study of Its ..
BU
11:56aSwitzerland Agency Approves Moderna and Pfizer/BioNTech Boosters
DJ
11:40aModerna Wins Swiss Regulator's Approval For Booster Dose of COVID-19 Vaccine
MT
11:31aModerna Signs MoU With African Union to Supply Up to 110 Million COVID-19 Vaccine Doses
MT
11:23aCOVID-19 vaccines safe for people with history of severe allergies, study finds
AQ
11:10aSWITZERLAND APPROVES MODERNA COVID B : Bloomberg
MT
10:13aModerna Secures Swiss Regulator's Approval For Booster Dose of COVID-19 Vaccine
MT
09:45aModerna Announces Swissmedic Authorizes Booster Dose of Moderna's COVID-19 Vaccine
BU
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 374 M - -
Net income 2021 12 558 M - -
Net cash 2021 13 559 M - -
P/E ratio 2021 11,7x
Yield 2021 -
Capitalization 141 B 141 B -
EV / Sales 2021 6,26x
EV / Sales 2022 5,55x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Last Close Price 349,56 $
Average target price 295,79 $
Spread / Average Target -15,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.234.60%141 099
LONZA GROUP AG31.93%60 646
IQVIA HOLDINGS INC.43.58%49 145
SEAGEN INC.0.22%31 933
CELLTRION, INC.-38.02%25 328
ALNYLAM PHARMACEUTICALS, INC.53.63%23 730